2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult

Cited by (1,000)

Items 201–300 of 1,000

1. Association of total cholesterol with severe acute pancreatitis: A U-shaped relationship
   Wandong Hong, Vincent Zimmer, Zarrin Basharat, Maddalena Zippi, Simon Stock, Wujun Geng, Xueqin Bao, Junfeng Dong, Jingye Pan, Mengtao Zhou · 2019 · Clinical Nutrition
2. Comparing a novel machine learning method to the Friedewald formula and Martin-Hopkins equation for low-density lipoprotein estimation
   Gurpreet Singh, Yasin Hussain, Zhuoran Xu, Evan Sholle, Kelly Michalak, Kristina Dolan, Benjamin C. Lee, Alexander R. van Rosendael, Zahra Fatima, Jessica M. Peña et al. · 2020 · PLoS ONE
3. Comparison of fasting and non-fasting lipid profiles in a large cohort of patients presenting at a community hospital
   Cartier, Louis-Jacques, Collins, Charlene, Lagacé, Mathieu, Douville, Pierre · 2018 · Clinical Biochemistry
4. Establishing age and sex dependent upper reference limits for the plasma lipoprotein (a) in a Chinese health check-up population and according to its relative risk of primary myocardial infarction
   Fengmei Cui, Fang Fang, Yong‐Ming He, Dong-Ping Cai, Jun Li He, Xiangjun Yang · 2018 · Clinica Chimica Acta
5. Role of Coronary Artery Calcium Testing for Risk Assessment in Primary Prevention of Atherosclerotic Cardiovascular Disease
   Philip Greenland, Donald M. Lloyd‐Jones · 2021 · JAMA Cardiology
6. Polygenic architecture and cardiovascular risk of familial combined hyperlipidemia
   Mark Trinder, Diana N. Vikulova, Simon Neil Pimstone, G.B. John Mancini, Liam R. Brunham · 2021 · Atherosclerosis
7. A Machine Learning Model Using Cardiac CT and MRI Data Predicts Cardiovascular Events in Obstructive Coronary Artery Disease
   Théo Pezel, Solenn Toupin, V. Bousson, Kenza Hamzi, Thomas Hovasse, Thierry Lefèvre, Bernard Chevalier, Thierry Unterseeh, Francesca Sanguineti, Stéphane Champagne et al. · 2025 · Radiology
8. What is the best diet for cardiovascular wellness? A comparison of different nutritional models
   Migliaccio, Silvia, Brasacchio, Caterina, Pivari, Francesca, Salzano, Ciro, Barrea, Luigi, Muscogiuri, Giovanna, Savastano, Silvia, Colao, Annamaria, on behalf of Obesity Programs of nutrition, Education, Research and Assessment (OPERA) Group · 2020 · International Journal of Obesity Supplements
9. Dietary patterns to promote cardiometabolic health
   Neha Jadeja Pagidipati, Pam R. Taub, Robert J. Ostfeld, Carol F. Kirkpatrick · 2024 · Nature Reviews Cardiology
10. Lipid Metabolism and Emerging Targets for Lipid-Lowering Therapy
    Daniel Gaudet, Jean‐Philippe Drouin‐Chartier, Patrick Couture · 2017 · Canadian Journal of Cardiology
11. Elevated lipoprotein (a) levels are associated with the presence and severity of coronary artery disease in patients with type 2 diabetes mellitus
    H.-W. Zhang, Xiangdi Zhao, Y.-L. Guo, Ying Gao, C.-G. Zhu, N Q Wu, J.-J. Li · 2018 · Nutrition Metabolism and Cardiovascular Diseases
12. Cardiovascular Efficacy and Safety of PCSK9 Inhibitors: Systematic Review and Meta-analysis Including the ODYSSEY OUTCOMES Trial
    Ricky D. Turgeon, Ross T. Tsuyuki, Gabor T. Gyenes, Glen J. Pearson · 2018 · Canadian Journal of Cardiology
13. Lipid management in rheumatoid arthritis: a position paper of the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology
    Ivana Hollan, Nicoletta Ronda, Patrick Hector Dessein, Stefan Agewall, George Athanasios Karpouzas, Juan Luis Tamargo, Alexander Niessner, Gianluigi Savarese, Giuseppe M.C. Rosano, Juan Carlos Kaski et al. · 2019 · European Heart Journal - Cardiovascular Pharmacotherapy
14. Association Between Statin Use and Cardiovascular Events After Carotid Artery Revascularization
    Mohamad Anas Hussain, Gustavo Saposnik, Sneha Raju, Konrad Salata, Muhammad Mamdani, Jack V. Tu, Deepak L. Bhatt, Subodh Verma, Mohammed A. Al-Omran · 2018 · Journal of the American Heart Association
15. Endothelial Dysfunction in Dyslipidaemia: Molecular Mechanisms and Clinical Implications
    Božidarka L. Zarić, Milan M. Obradovic, Andreja Trpković, Maciej Banach, Dimitri P. Mikhailidis, Esma R. Isenović · 2019 · Current Medicinal Chemistry
16. Low-density lipoprotein cholesterol goal attainment rates in high-risk patients with cardiovascular diseases and diabetes mellitus in Korea: a retrospective cohort study
    Ye Yang, Bo Ram Yang, Mi‐Sook Kim, Yunji Hwang, Sung Hee Choi · 2020 · Lipids in Health and Disease
17. Cost-Effectiveness of Polygenic Risk Scores to Guide Statin Therapy for Cardiovascular Disease Prevention
    Michel Kiflen, Ann Le, Shihong Mao, Ricky Lali, Sukrit Narula, Feng Xie, Guillaume Paré · 2022 · Circulation Genomic and Precision Medicine
18. Cardiovascular Disease Risk–Based Statin Utilization and Associated Outcomes in a Primary Prevention Cohort: Insights From a Large Health Care Network
    Anum Saeed, Jianhui Zhu, Floyd W. Thoma, Oscar C. Marroquin, Aryan Aiyer, Anandita Agarwala, Salim S. Virani, Martha Gulati, Joon S. Lee, Steven E. Reís et al. · 2021 · Circulation Cardiovascular Quality and Outcomes
19. Development and validation of a deep-learning model to predict 10-year atherosclerotic cardiovascular disease risk from retinal images using the UK Biobank and EyePACS 10K datasets
    Ehsan Vaghefi, David Squirrell, Song Yang, Songyang An, Li Ying Xie, Mary K Durbin, Huiyuan Hou, John Marshall, Jacqueline Baras Shreibati, Michael V. McConnell et al. · 2024 · Cardiovascular Digital Health Journal
20. Evaluation of GPT-4 for 10-year cardiovascular risk prediction: Insights from the UK Biobank and KoGES data
    Changho Han, Dong Won Kim, Songsoo Kim, Seng Chan You, Jin Young Park, SungA Bae, Dukyong Yoon · 2024 · iScience
21. ApoB100 and Atherosclerosis: What’s New in the 21st Century?
    Dimitris C. Kounatidis, Natalia G. Vallianou, Aikaterini Poulaki, Angelos A Evangelopoulos, Fotis Panagopoulos, Theodora Stratigou, Eleni V. Geladari, Ιrene Karampela, Μaria Dalamaga · 2024 · Metabolites
22. Approach to the detection and management of chronic kidney disease: What primary care providers need to know.
    Allan K. Grill, Scott Brimble · 2018 · Europe PMC (PubMed Central)
23. Global think tank on the clinical considerations and management of lipoprotein(a): The top questions and answers regarding what clinicians need to know
    Salim S. Virani, Marlys L. Koschinsky, Lisa V. Maher, Anurag Mehta, Carl E. Orringer, Raul Dias Santos, Michael David Shapiro, Joseph J. Saseen · 2022 · Progress in Cardiovascular Diseases
24. Preventive care recommendations to promote health equity
    Nav Persaud, Areesha Sabir, Hannah Woods, Ambreen Sayani, Arnav Agarwal, Muna Chowdhury, Kathleen de Leon-Demare, Somtochukwu Ibezi, Saadia Hameed Jan, Alan Katz et al. · 2023 · Canadian Medical Association Journal
25. Poor Adherence to Dietary Guidelines Among French-Speaking Adults in the Province of Quebec, Canada: The PREDISE Study
    Didier Brassard, Catherine Laramée, Louise Corneau, Catherine Bégin, Mathieu F. Bélanger, Luigi Bouchard, Charles Couillard, Sophie Desroches, Julie Houle, Marie‐France Langlois et al. · 2018 · Canadian Journal of Cardiology
26. Prescribing statins among patients with type 2 diabetes: The clinical gap between the guidelines and practice
    M.A. Hammad, Syed Azhar Syed Sulaiman, Nor Azizah Aziz, Dzul Azri Mohamed Noor · 2019 · Journal of Research in Medical Sciences
27. Effectiveness of Interventions Aimed at Increasing Statin-Prescribing Rates in Primary Cardiovascular Disease Prevention
    Robert T. Sparrow, Anam M Khan, Laura Legere, Dennis T. Ko, Cynthia Anne Jackevicius, Shaun G. Goodman, Todd J. Anderson, Dawn Stacey, Ildiko Tiszovszky, Michael E. Farkouh et al. · 2019 · JAMA Cardiology
28. Prediction of Cardiovascular Disease Risk Accounting for Future Initiation of Statin Treatment
    Zhe Xu, Matthew Arnold, David Stevens, Stephen K. Kaptoge, Lisa A M Pennells, Michael J. Sweeting, Jessica Barrett, Emanuele Di Angelantonio, Angela Wood · 2021 · American Journal of Epidemiology
29. Effects of Soy Protein Containing of Isoflavones and Isoflavones Extract on Plasma Lipid Profile in Postmenopausal Women as a Potential Prevention Factor in Cardiovascular Diseases: Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Agnieszka Barańska, Agata Błaszczuk, Wiesław Maciej Kanadys, Bożena Baczewska, Marian Jędrych, Ewelina Wawryk‐Gawda, Małgorzata Polz‐Dacewicz · 2021 · Nutrients
30. How should public health recommendations address Lp(a) measurement, a causative risk factor for cardiovascular disease (CVD)?
    Alberico Luigi Catapano, Magdalena Daccord, Elaine Damato, Steve Eric Humphries, R. Dermot G. Neely, Børge Grønne Nordestgaard, Michele Pistollato, Elisabeth Steinhagen‐Thiessen · 2022 · Atherosclerosis
31. Hyperlipidaemia in primary biliary cholangitis: treatment, safety and efficacy
    Martín Wah‐Suárez, Christopher J. Danford, Vilas R. Patwardhan, Zhenghui Gordon Jiang, Alan Bonder · 2019 · Frontline Gastroenterology
32. Non-traditional lipid profiles associated with ischemic stroke not hemorrhagic stroke in hypertensive patients: results from an 8.4 years follow-up study
    Jia Zheng, Zhaoqing Sun, Xingang Zhang, Li Zhao, Xiaofan Guo, Yanxia Xie, Yingxian Sun, Liqiang Zheng · 2019 · Lipids in Health and Disease
33. Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Current Understanding and Future Perspectives
    Min Wu, Kaizu Xu, Yulong Guo, J. Yu, Y. Wu, Liming Lin · 2019 · Cardiovascular Drugs and Therapy
34. Apolipoprotein profiling as a personalized approach to the diagnosis and treatment of dyslipidaemia
    Renee Ruhaak, L, van der Laarse, Arnoud, Cobbaert, Christa M · 2019 · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine
35. Real-World Insights Into Evolocumab Use in Patients With Hyperlipidemia: Canadian Analysis From the ZERBINI Study
    Milan Gupta, G.B. John Mancini, Rajvi J. Wani, Vineeta Ahooja, Jean Bergeron, Priya Manjoo, Amritanshu Shekhar Pandey, Maureen T. Reiner, Johnny Beltran, Thiago Oliveira et al. · 2022 · CJC Open
36. Cardiovascular Events After Exposure to Nilotinib in Chronic Myeloid Leukemia: Long-term Follow-up
    Nazanin Aghel, Jeffrey Howard Lipton, Eshetu G. Atenafu, Dennis Dong Hwan Kim, Diego Delgado · 2017 · Clinical Lymphoma Myeloma & Leukemia
37. Lipoprotein(a) as a risk factor for calcific aortic valvulopathy in heterozygous familial hypercholesterolemia
    Alpo F. Vuorio, Gerald Francis Watts, Petri T. Kovanen · 2018 · Atherosclerosis
38. A Randomized Clinical Efficacy Trial of Red Yeast Rice (Monascus pilosus) Against Hyperlipidemia
    Tien-Ju Wang, Angela Shin‐Yu Lien, Jiun-Liang Chen, Cheng-Hui Lin, Yin-Shuo Yang, Sien‐Hung Yang · 2019 · The American Journal of Chinese Medicine
39. Important food sources of fructose-containing sugars and adiposity: A systematic review and meta-analysis of controlled feeding trials
    Laura Chiavaroli, Annette Cheung, Sabrina Ayoub‐Charette, Amna Ahmed, Danielle Lee, Fei Au‐Yeung, Xinye Qi, Songhee Back, Néma D. McGlynn, Vanessa Ha et al. · 2023 · American Journal of Clinical Nutrition
40. PEER simplified lipid guideline 2023 update
    Michael R. Kolber, Scott W Klarenbach, Michel Cauchon, Mike Cotterill, Loren D. Regier, Raelene Marceau, Norah Duggan, Rebecca Whitley, Alex S. Halme, Tanis Poshtar et al. · 2023 · Canadian Family Physician
41. Elevated plasma lipoprotein(a) levels were associated with increased risk of cardiovascular events in Chinese patients with stable coronary artery disease
    Wen Dai, Junke Long, Ying Cheng, Yaqin Chen, Shui‐Ping Zhao · 2018 · Scientific Reports
42. Barriers and Facilitators to Using Statins: A Qualitative Study With Patients and Family Physicians
    Sonia Butalia, Rachelle C.W. Lee-Krueger, Kerry A. McBrien, Alexander A. C. Leung, Todd J. Anderson, Hude Quan, Christopher T Naugler, Guanmin Chen, David J.T. Campbell · 2020 · CJC Open
43. Practical Guidance for Food Consumption to Prevent Cardiovascular Disease
    Paul John Nestel, Lawrence Joseph Beilin, Peter Marshall Clifton, Gerald Francis Watts, Trevor Anthony Mori · 2020 · Heart Lung and Circulation
44. Underuse of cardiorenal protective agents in high-risk diabetes patients in primary care: a cross-sectional study
    Robin C. Hao, Tyler W. Myroniuk, Taylor McGuckin, Donna Patricia Manca, Denise Lynn Campbell-Scherer, Darren Lau, Roseanne O. Yeung · 2022 · BMC Family Practice
45. Nonfasting lipid testing: the new standard for cardiovascular risk assessment
    Pol Darras, André Mattman, Gordon A. Francis · 2018 · Canadian Medical Association Journal
46. Statins for primary prevention in adults aged 75 years and older: A nationwide population-based case-control study
    Ji Eun Jun, In-Jin Cho, Kyungdo Han, In‐Kyung Jeong, Kyu Jeung Ahn, Ho Yeon Chung, You‐Cheol Hwang · 2019 · Atherosclerosis
47. Value of Carotid Ultrasound in Cardiovascular Risk Stratification in Patients With Psoriatic Disease
    Curtis Sobchak, Shadi Akhtari, Paula Harvey, Dafna D. Gladman, Vinod Chandran, Richard J. Cook, Lihi Eder · 2019 · Arthritis & Rheumatology
48. Chronic kidney disease measures for cardiovascular risk prediction
    Yejin Mok, Shoshana H. Ballew, Kunihiro Matsushita · 2021 · Atherosclerosis
49. Lipoprotein (a)-Related Inflammatory Imbalance: A Novel Horizon for the Development of Atherosclerosis
    Ting Qin, Tianyi Ma, Kang Huang, Shijuan Lu, Jianghua Zhong, Jian‐Jun Li · 2024 · Current Atherosclerosis Reports
50. Cardiovascular Disease Prognostic Models in Latin America and the Caribbean: A Systematic Review
    Rodrigo Martin Carrillo-Larco, Carlos Altez-Fernandez, Niels Victor Pacheco-Barrios, Claudia Bambs S., Vilma Edith Irazola, J. Jaime Miranda, Goodarz Danaei, Pablo Perel · 2019 · Global Heart
51. Association of Dietary Phytosterols with Cardiovascular Disease Biomarkers in Humans
    Ramandeep Kaur, Semone B. Myrie · 2020 · Lipids
52. Assessment of cardiovascular risk tools as predictors of cardiovascular disease events in systemic lupus erythematosus
    Jagan Sivakumaran, Paula Harvey, Ahmed Omar, Oshrat E Tayer-Shifman, Murray B. Urowitz, Dafna D. Gladman, Nicole M. Anderson, Jiandong Su, Zahi Touma · 2021 · Lupus Science & Medicine
53. Lipoprotein (a): Recent Updates on a Unique Lipoprotein
    Anum Saeed, Sina Kinoush, Salim S. Virani · 2021 · Current Atherosclerosis Reports
54. Cardiovascular Risk Stratification in Diabetic Retinopathy via Atherosclerotic Pathway in COVID-19/Non-COVID-19 Frameworks Using Artificial Intelligence Paradigm: A Narrative Review
    Smiksha Munjral, Mahesh A. Maindarkar, Puneet Ahluwalia, Anudeep Puvvula, Ankush D. Jamthikar, Tanay Jujaray, Neha Suri, Sudip Paul, Rajesh Pathak, Luca Saba et al. · 2022 · Diagnostics
55. Machine-Learning Score Using Stress CMR for Death Prediction in Patients With Suspected or Known CAD
    Théo Pezel, Francesca Sanguineti, Philippe Garot, Thierry Unterseeh, Stéphane Champagne, Solenn Toupin, Stéphane Morisset, Thomas Hovasse, Alyssa Faradji, Tania Ah-Sing et al. · 2022 · JACC. Cardiovascular imaging
56. 2023 Guidelines of the Taiwan Society of Cardiology on the Diagnosis and Management of Chronic Coronary Syndrome.
    Kwo‐Chang Ueng, Chern‐En Chiang, Ting‐Hsing Chao, Yen‐Wen Wu, Wen-Lieng Lee, Yi‐Heng Li, Ke-Hsin Ting, Chun-Hung Su, Hung‐Ju Lin, Ta‐Chen Su et al. · 2023 · PubMed Central
57. Lipoproteins, Cholesterol, and Atherosclerotic Cardiovascular Disease in East Asians and Europeans
    Takahito Doi, Anne Langsted, Børge Grønne Nordestgaard · 2023 · Journal of Atherosclerosis and Thrombosis
58. Effectiveness of Pharmacist Interventions on Cardiovascular Risk in Patients With CKD: A Subgroup Analysis of the Randomized Controlled RxEACH Trial
    Yazid N. Al Hamarneh, Ross T. Tsuyuki, Charlotte Jones, Braden Manns, Marcello A. Tonelli, Nairne Scott‐Douglas, Kailash K Jindal, Wendy Tink, Brenda R. Hemmelgarn · 2017 · American Journal of Kidney Diseases
59. Sex differences in psychosocial and cardiometabolic health among patients completing cardiac rehabilitation
    Tasuku Terada, Daniele Chirico, Heather E. Tulloch, Kyle M. Scott, Andrew Pipe, Jennifer L. Reed · 2019 · Applied Physiology Nutrition and Metabolism
60. Statin-prescribing trends for primary and secondary prevention of cardiovascular disease.
    Felicity Brown, Alexander G. Singer, Alan Katz, Gerald Konrad · 2017 · Europe PMC (PubMed Central)
61. Evaluation of Plasma Adenosine as a Marker of Cardiovascular Risk: Analytical and Biological Considerations
    Trevor Simard, Richard G. Jung, Alisha Labinaz, Mohammad Ali Faraz, Francisco Daniel Ramirez, Pietro Di Santo, Dylan Perry‐Nguyen, Ian Pitcher, Pouya Motazedian, Chantal Gaudet et al. · 2019 · Journal of the American Heart Association
62. Associations Between Cardiovascular Risk Factors and Audiometric Hearing: Findings From the Canadian Longitudinal Study on Aging
    Paul Thomas Mick, Rasel Kabir, Margaret Kathleen Pichora-Fuller, Charlotte Jones, Lindy M.R. Moxham, Natalie A. Phillips, Emily Urry, Walter Wittich · 2023 · Ear and Hearing
63. Cardiovascular Risk Assessment and Follow-Up of Women After Hypertensive Disorders of Pregnancy:A Prospective Cohort Study
    Rachel A. Gladstone, Jessica Pudwell, Kara A. Nerenberg, Steven A. Grover, Graeme Neil Smith · 2019 · Journal of Obstetrics and Gynaecology Canada
64. Lipoprotein(a) and Cardiovascular Outcomes in Patients with Previous Myocardial Infarction: A Prospective Cohort Study
    Ye‐Xuan Cao, Huiwen Zhang, Jing‐Lu Jin, Huihui Liu, Yan Zhang, Meng Zhang, Ying Gao, Yuan‐Lin Guo, Na‐Qiong Wu, Cheng‐Gang Zhu et al. · 2020 · Thrombosis and Haemostasis
65. Etiology and Management of Dyslipidemia in Patients With Cancer
    Mikhail de Jesus, Turab Jawaid Mohammed, Meghana Singh, John Glenn Tiu, Agnes S. Kim · 2022 · Frontiers in Cardiovascular Medicine
66. Cardiovascular disease/stroke risk stratification in deep learning framework: a review
    Mrinalini Bhagawati, Sudip Paul, Sushant Agarwal, Athanasios Protogeron, Petros Paul Sfikakis, George D. Kitas, Narendra Nath Khanna, Zoltán Ruzsa, Aditya Sharma, Omerzu Tomazu et al. · 2023 · Cardiovascular Diagnosis and Therapy
67. Drug Therapy of Dyslipidemia in the Elderly
    Srikanth Yandrapalli, Shashvat Gupta, Gabriela Andries, Howard A. Cooper, Wilbert S. Aronow · 2019 · Drugs & Aging
68. Pediatric Dyslipidemia—Beyond Familial Hypercholesterolemia
    Julieta Lazarte, Robert Alexander Hegele · 2020 · Canadian Journal of Cardiology
69. The effect of a 6-month ketogenic medium-chain triglyceride supplement on plasma cardiometabolic and inflammatory markers in mild cognitive impairment.
    Étienne Myette‐Côté, Valérie St‐Pierre, Sandrine Beaulieu, Christian‐Alexandre Castellano, Mélanie Fortier, Mélanie Plourde, Christian Bocti, Tamàs Fülöp, Stephen C. Cunnane · 2020 · Prostaglandins Leukotrienes and Essential Fatty Acids
70. Expert position statements: comparison of recommendations for the care of adults and youth with elevated lipoprotein(a)
    Don P. Wilson, Marlys L. Koschinsky, Patrick M. Moriarty · 2021 · Current Opinion in Endocrinology Diabetes and Obesity
71. Canadian Society of Clinical Chemists Harmonized Clinical Laboratory Lipid Reporting Recommendations on the Basis of the 2021 Canadian Cardiovascular Society Lipid Guidelines
    Nicole White-Al Habeeb, Victoria Higgins, Allison A. Venner, Dana Bailey, Daniel R. Beriault, Christine P. Collier, Khosrow Adeli · 2022 · Canadian Journal of Cardiology
72. Effects of lifestyle interventions on cardiovascular risk factors in South Asians: a systematic review and meta-analysis
    Jayneel Limbachia, Mohitkumar S Ajmeri, Benjamin J Keating, Russell J. de Souza, Sonia Savitri Anand · 2022 · BMJ Open
73. Clinical Features and Outcomes of Acute Coronary Syndrome in Women With Previous Pregnancy Complications
    Sophie Grand’Maison, Louise Pilote, Kenny Schlosser, Duncan John Stewart, Marisa Okano, Natalie Dayan · 2017 · Canadian Journal of Cardiology
74. Should statin guidelines consider patient preferences? Eliciting preferences of benefit and harm outcomes of statins for primary prevention of cardiovascular disease in the sub-Saharan African and European contexts
    Henock G. Yebyo, Hélène Eloise Aschmann, Tsung Yu, Milo Alan Puhan · 2018 · BMC Cardiovascular Disorders
75. Lipoprotein (a) and 10-year Cardiovascular Disease Incidence in Apparently Healthy Individuals: A Sex-based Sensitivity Analysis from ATTICA Cohort Study
    Matina Kouvari, Demosthenes B. Panagiotakos, Christina A. Chrysohoou, Ekavi N. Georgousopoulou, Mary Yannakoulia, Dimitrios M. Tousoulis, Christos E. Pitsavos · 2019 · Angiology
76. The gut microbiota is associated with clinical response to statin treatment in patients with coronary artery disease
    Lijun Wang, Weiwei Zhou, Manyun Guo, Yiming Hua, Baihua Zhou, Xinyin Li, Xinxin Zhang, Jiakun Dong, Xiumei Yang, Yang Wang et al. · 2021 · Atherosclerosis
77. Omega‐3 fatty acids for the prevention of atherosclerotic cardiovascular disease
    Arden R. Barry, Dave L. Dixon · 2021 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
78. Association of Lipoprotein (a) and Standard Modifiable Cardiovascular Risk Factors With Incident Myocardial Infarction: The Mass General Brigham Lp(a) Registry
    A. Shiyovich, A. Berman, Stephanie A. Besser, D. Biery, Gurleen Kaur, S. Divakaran, Avinainder Singh, D. Huck, Brittany N. Weber, Jorge Plutzky et al. · 2024 · Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease
79. Lipoprotein(a): new insights from modern genomics
    Mehdi Shahriyari Afshar, George Thanassoulis · 2017 · Current Opinion in Lipidology
80. 18 F-Sodium Fluoride Imaging of Coronary Atherosclerosis in Ambulatory Patients With Diabetes Mellitus
    Paolo Raggi, Peter Alexander Senior, Shima Shahbaz, Padma Kaul, Ryan Hung, Richard A. Coulden, Roseanne O. Yeung, Jonathan T. Abele · 2019 · Arteriosclerosis Thrombosis and Vascular Biology
81. Lipoprotein(a) – Link between Atherogenesis and Thrombosis
    Danica D Labudović, Irena Kostovska, Katerina Tosheska Trajkovska, Svetlana Cekovska, Julijana Brezovska Kavrakova, Sonja Topuzovska · 2019 · Prague Medical Report
82. LDL particle number and size and cardiovascular risk: anything new under the sun?
    Janie Allaire, Cécile Vors, Patrick Couture, Benoı̂t Lamarche · 2017 · Current Opinion in Lipidology
83. Treatment and Low-Density Lipoprotein Cholesterol Management in Patients Diagnosed With Clinical Atherosclerotic Cardiovascular Disease in Alberta
    Guanmin Chen, Megan S. Farris, Tara Cowling, Stephen M. Colgan, Pin Xiang, L. Pericleous, Raina M. Rogoza, Ming‐Hui Tai, Todd J. Anderson · 2019 · Canadian Journal of Cardiology
84. Recommendations for statin management in primary prevention: disparities among international risk scores
    G.B. John Mancini, Arnold Ryomoto, Eunice Yeoh, Liam R. Brunham, Robert Alexander Hegele · 2023 · European Heart Journal
85. Implantable Self-Reporting Stents for Detecting In-Stent Restenosis and Cardiac Functional Dynamics
    Nomin‐Erdene Oyunbaatar, Dong‐Su Kim, Arunkumar Shanmugasundaram, Su‐Hwan Kim, Yun‐Jin Jeong, Juyeong Jo, Kyeongha Kwon, Eunpyo Choi, Dong‐Weon Lee · 2023 · ACS Sensors
86. New Insights Into the Treatment of Hyperlipidemia: Pharmacological Updates and Emerging Treatments
    Seema Abbasi, Adnan Ahmed Khan, Muhammad W. Choudhry · 2024 · Cureus
87. Molecular, Population, and Clinical Aspects of Lipoprotein(a): A Bridge Too Far?
    Natalie C. Ward, Karam Kostner, DAVID R. SULLIVAN, Paul John Nestel, Gerald Francis Watts · 2019 · Journal of Clinical Medicine
88. Integration of estimated glomerular filtration rate biomarker in image-based cardiovascular disease/stroke risk calculator: a south Asian-Indian diabetes cohort with moderate chronic kidney disease
    Vijay Viswanathan, Ankush D. Jamthikar, Deep Gupta, Anudeep Puvvula, Narendra Nath Khanna, Luca Saba, Klaudija Višković, Sophie I. Mavrogeni, Monika Turk, John R. Laird et al. · 2020 · International Angiology
89. Familial Hypercholesterolemia and Elevated Lipoprotein(a): Cascade Testing and Other Implications for Contextual Models of Care
    Wann Jia Loh, Dick C. Chan, Pedro Mata, Gerald Francis Watts · 2022 · Frontiers in Genetics
90. The functions of apolipoproteins and lipoproteins in health and disease
    Zijun Ma, Jixin Zhong, Wei Tu, Shiliang Li, Jun Chen · 2024 · Molecular Biomedicine
91. Expert opinion on the integration of combination therapy into the treatment algorithm for the management of dyslipidaemia: the integration of ezetimibe and bempedoic acid may enhance goal attainment
    Klaus Georg Parhofer, Carlos Aguíar, Maciej Banach, Heinz Drexel, Ioanna Gouni‐Berthold, Leopoldo Pérez de Isla, Ernst R. Rietzschel, Alberto Zambon, Kausik Kumar Ray · 2025 · European Heart Journal - Cardiovascular Pharmacotherapy
92. Pregnancy-related cardiovascular risk indicators: Primary care approach to postpartum management and prevention of future disease.
    Monica Graves, Kelly Howse, Jessica Pudwell, Graeme Neil Smith · 2019 · Europe PMC (PubMed Central)
93. The Role of Statins in Current Guidelines
    Fabiana Hanna Rached, Raul Dias Santos · 2020 · Current Atherosclerosis Reports
94. Cardiovascular disease and stroke risk assessment in patients with chronic kidney disease using integration of estimated glomerular filtration rate, ultrasonic image phenotypes, and artificial intelligence: a narrative review
    Ankush D. Jamthikar, Anudeep Puvvula, Deep Gupta, Amer M. Johri, Vijay Nambi, Narendra Nath Khanna, Luca Saba, Sophie I. Mavrogeni, John R. Laird, Gyan Pareek et al. · 2021 · International Angiology
95. Attainment of Recommended Lipid Targets in Patients With Familial Hypercholesterolemia: Real-World Experience With PCSK9 Inhibitors
    Omar Razek, Lubomira Cermakova, Hamidreza Armani, Terry Lee, Gordon A. Francis, G.B. John Mancini, Jiri J Frohlich, Liam R. Brunham · 2018 · Canadian Journal of Cardiology
96. Statin therapy in athletes and patients performing regular intense exercise – Position paper from the International Lipid Expert Panel (ILEP)
    Niki Katsiki, Dimitri P. Mikhailidis, Gani Bajraktari, André R. Miserez, Arrigo F.G. Cicero, Éric Bruckert, Maria-Corina Șerban, Erkin Mirsaidovich Mirrakhimov, Fahad Alnouri, Željko Reiner et al. · 2020 · Pharmacological Research
97. Lessons from animal nutritionists: dietary amino acid requirement studies and considerations for healthy aging studies
    Anna Kate K Shoveller, Leslie L. McKnight, Katharine M Wood, John P. Cant · 2018 · Annals of the New York Academy of Sciences
98. Standardization of laboratory and lipid profile evaluation: A call for action with a special focus in 2016 ESC/EAS dyslipidaemia guidelines – Full report
    Pedro Marques da Silva, João Sequeira Duarte, Pedro VON HAFE, Victor Machado Gil, Jorge Nunes de Oliveira, Germano de Sousa · 2018 · Atherosclerosis Supplements
99. Consistent LDL‐C response with evolocumab among patient subgroups in PROFICIO: A pooled analysis of 3146 patients from phase 3 studies
    Erik S.G. Stroes, Jennifer G. Robinson, Frederick Johan Raal, Robert Dufour, David Sullivan, Helina Kassahun, Yuhui Ma, Scott M. Wasserman, Michael J. Koren · 2018 · Clinical Cardiology
100. Rate of dyslipidemia higher among women living with HIV: A comparison of metabolic and cardiovascular health in a cohort to study aging in HIV
     EAB Russell, AYK Albert, Hélène C F Côté, AYY Hsieh, Ariel Nesbitt, AR Campbell, EJ Maan, Jason C. Brophy, Neora Pick, Melanie C. M. Murray · 2020 · HIV Medicine